Akari Therapeutics Plc (AKTX)
11.47
+0.63
(+5.81%)
USD |
NASDAQ |
Sep 04, 16:00
11.63
+0.16
(+1.39%)
After-Hours: 20:00
Akari Therapeutics Research and Development Expense (Quarterly) : 2.081M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.081M |
| March 31, 2026 | 1.457M |
| December 31, 2025 | 1.084M |
| September 30, 2025 | 0.2474M |
| June 30, 2025 | 0.6753M |
| March 31, 2025 | 0.813M |
| December 31, 2024 | 1.235M |
| September 30, 2024 | 0.143M |
| June 30, 2024 | 3.314M |
| March 31, 2024 | 2.279M |
| March 31, 2023 | 1.731M |
| June 30, 2022 | 2.851M |
| March 31, 2022 | 2.140M |
| December 31, 2021 | 3.851M |
| September 30, 2021 | 2.637M |
| June 30, 2021 | 4.367M |
| March 31, 2021 | 7.059M |
| December 31, 2020 | 4.660M |
| September 30, 2020 | 1.780M |
| June 30, 2020 | 6.041M |
| March 31, 2020 | 5.464M |
| December 31, 2019 | 5.833M |
| Date | Value |
|---|---|
| September 30, 2019 | 4.666M |
| June 30, 2019 | 3.594M |
| March 31, 2019 | 2.554M |
| December 31, 2018 | 2.362M |
| September 30, 2018 | 3.304M |
| June 30, 2018 | 5.121M |
| March 31, 2018 | 1.008M |
| December 31, 2017 | 7.118M |
| September 30, 2017 | 6.382M |
| June 30, 2017 | 3.782M |
| March 31, 2017 | 6.003M |
| December 31, 2016 | 6.017M |
| September 30, 2016 | 4.372M |
| June 30, 2016 | 5.443M |
| March 31, 2016 | 1.423M |
| December 31, 2015 | 1.915M |
| September 30, 2015 | 1.316M |
| June 30, 2015 | 0.138M |
| March 31, 2015 | 1.455M |
| December 31, 2013 | 0.3514M |
| September 30, 2013 | 0.103M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| DBV Technologies SA | 28.96M |
| Cellectis SA | 20.89M |
| argenx SE | -- |
| Autolus Therapeutics Plc | 27.95M |
| Evaxion AS | 2.331M |